Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults

NCT ID: NCT06932679

Last Updated: 2025-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-24

Study Completion Date

2028-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to explore how young adults, older adults and people with Parkinson's disease (PwP), perceive their abilty to cross obstacles while walking, and how this perception is related to their actual performance of obstacle crossing and disease-related motor and cognitive impairments. The study will explore this percepeption and the actual performance in different walking environments(floor, synthetic grass turf). Understanding how people perceive obstacles may help improve rehabilitation methods and reduce the risk of falls. The study will take place at the Motor Performance Laboratory, University of Haifa, and will include walking tasks, eye-tracking measurements, and motor and cognitive assessments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study investigates the role of affordance perception - the ability to perceive opportunities for action - during obstacle crossing in people with Parkinson's disease (PwP). Falls are highly prevalent in PwP, often resulting from tripping over obstacles. While previous research has mainly focused on gait impairments, this study uniquely examines the perceptual stage that precedes movement and the association between perception, cognition, and motor performance.

Participants will include 60 PwP and 120 healthy adults (60 older adults and 60 young adults). All participants will perform walking tasks involving obstacle crossing under different environmental conditions (e.g., different obstacle heights and surfaces). Prior to walking, participants will judge whether they can safely cross the obstacle. Eye-tracking glasses will measure visual exploration patterns to assess how participants scan the environment. Additionally, walking variables such as speed and step length, will be recorded using wearable sensors.

The study will explore:

1. Differences in affordance perception between PwP and healthy adults.
2. Associations between motor and cognitive impairments and affordance perception in PwP.
3. How affordance perception relates to gait performance during obstacle crossing.

Results from this study may help to develop new intervention strategies aimed at improving safe walking and obstacle negotiation in PwP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease (PD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Parkinson's Disease

Participants diagnosed with Parkinson's disease (PwP), aged 60-80 years, able to walk independently outdoors.

Assessment of Gait and Visual Exploration

Intervention Type OTHER

Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.

Healthy Older Adults

Healthy adults aged 60-80 years, without neurological or orthopedic conditions affecting gait.

Assessment of Gait and Visual Exploration

Intervention Type OTHER

Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.

Healthy Young Adults

Healthy adults aged 20-30 years, without neurological or orthopedic conditions affecting gait.

Assessment of Gait and Visual Exploration

Intervention Type OTHER

Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment of Gait and Visual Exploration

Participants will perform walking tasks involving obstacle crossing while their gait and visual exploration patterns are recorded using wearable sensors and eye-tracking glasses. This is a non-invasive observational study with no therapeutic intervention.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants aged 20 to 80 years.
* Ability to walk independently outdoors without assistive devices.
* For Parkinson's Disease (PD) group: Diagnosis of PD confirmed by medical records.
* For healthy control groups: No neurological or orthopedic conditions affecting gait.

Exclusion Criteria

* Feezing of gait (for PD group only), based on a score greater than 0 on the Freezing of Gait Questionnaire.
* Severe visual impairment that cannot be corrected with glasses or lenses.
* Cognitive impairment, defined as a score below 18 on the telephone-based Mini-Mental State Examination (MMSE).
* Any orthopedic condition, pain, or other medical condition that may affect walking, based on self-report.
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Haifa, Israel

UNKNOWN

Sponsor Role collaborator

University of Haifa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Galit Yogev-Seligmann

Senior Lecturer, Department of Occupational Therapy, Faculty of Social Welfare and Health Sciences, University of Haifa

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Galit Yogev Seligmann, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Haifa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Haifa, Motor Performance Laboratory

Haifa, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Galit Yogev Seligmann, PhD

Role: CONTACT

+972-53-5315761

Michal Kafri, PhD

Role: CONTACT

+972-58-6862261

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Galit Yogev Seligmann, PhD

Role: primary

+972-53-5315761

Michal Kafri, PhD

Role: backup

+972-58-6862261

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1561/25

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.